Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07507344 · ClinicalTrials.gov registry record · NA
Beverage Hydration Index of Different Solutions
A NA study, sponsored by University of Memphis.
- Recruiting
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT07507344: Recruiting NA study, sponsored by University of Memphis.
NCT07507344 is a NA study that is actively recruiting participants, run by University of Memphis. The registered enrollment target is 30 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07507344, a NA study, is actively recruiting participants, sponsored by University of Memphis.
- RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
In this study, the impact of two electrolyte hydration stick products (Hydramin containing an electrolyte/amino acid formulation and an identical electrolyte product with the amino-acids replaced with carbohydrate, dextrose) dissolved in 1 liter of water will be assessed and compared to a control (1 liter Smart Water). It is hypothesized that the addition of amino acids and glycine should improve the Beverage Hydration Index above water alone and perform comparably to the carbohydrate rich solution. This study will focus on general population (not athletes) and follow very similar approaches used in previous studies within the Center for Nutraceutical and Dietary Supplements Research, with the addition of blood glucose testing and body water measurements. Hydration will be assessed via fluid balance (the difference between the amount of water consumed and passed as urine) and calculations of beverage hydration index (the relative amount of urine passed after consumption of a drink compared to water)as well as time in positive fluid balance, and specific gravity, and sodium and potassium in urine. Blood glucose before and following consumption using finger pricks and a glucometer will also be assessed.
Primary Outcome
Beverage Hydration Index calculated as mass of urine collected following control (water) divided by the mass of urine collected following treatment
Interventions
- DIETARY_SUPPLEMENT Water
- DIETARY_SUPPLEMENT Hydramin hydration solution
- DIETARY_SUPPLEMENT Carbohydrate and Electrolyte hydration solution
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2026-02-23 |
| Est. Completion | 2026-06-30 |
| Phase | NA |
What NCT07507344 shows while recruiting
NCT07507344 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 3 interventions - of which Water is the first listed.
NCT07507344 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07507344 about?
NCT07507344 is a clinical study titled "Beverage Hydration Index of Different Solutions". In this study, the impact of two electrolyte hydration stick products (Hydramin containing an electrolyte/amino acid formulation and an identical electrolyte product with the amino-acids replaced with carbohydrate, dextrose) dissolved in 1 liter of water will be assessed and compared to a control (1...
What is the current status of trial NCT07507344?
This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2026-02-23. Estimated completion is 2026-06-30.
What interventions are being tested in trial NCT07507344?
The interventions under investigation include: Water (DIETARY_SUPPLEMENT), Hydramin hydration solution (DIETARY_SUPPLEMENT), Carbohydrate and Electrolyte hydration solution (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT07507344?
This trial is sponsored by University of Memphis, which has 35 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07507344's enrollment target sits among peer trials
30 1593rd of 2000 higher than 299 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI